Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Clinical Pharmacologal Profile of Low Molecular Weight Heparins

  • Conference paper
New Trends in Haemostasis

  • 65 Accesses

Abstract

In postoperative care (Kakkar 1982, Bergqvist 1986, Turpie 1986) and in medical patients (Dahan 1986, Harenberg 1987a, Harenberg 1990) various low molecular weight (LMW) heparins have been shown to prevent thromboembolism with a single dose daily, while treatment for thromboembolism appears to require repeated daily subcutaneous injections (Holm 1986, Janvier 1987).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Augustin J, Greten H (1979) The role of lipoprotein lipase, molecular properties and clinical relevance. In: Paoletti R, Gotto AM (Eds). Atherosclerosis Reviews. Vol. 5, pp. 91–124. Raven Press, New York

    Google Scholar 

  • Basu D, Gallus A, Hirsh J, Cade J (1972) A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. New Engl J Med 287: 324–327

    Article  PubMed  CAS  Google Scholar 

  • Bergqvist D, Burmark US, Frisell J, Hallböök T, Lindblad B, Risberg B, Törngren S, Wallin G (1986) Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis. Br J Surg 73: 204–208

    Article  PubMed  CAS  Google Scholar 

  • Dahan R, Houlbert D, Caulin C, Cuzin E, Viltart C, Woler M, Segrestaa JM (1986) Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: A randomized double-blind trial. Haemostasis 16: 159–164

    PubMed  CAS  Google Scholar 

  • Gray E, Begtsson-Olivecrona G, Olivecrona T, Barrowcliffe TW (1986) The anti-Xa activity of human hepatic triglyceride lipase ( HTGL ). J Lab Clin Med 109: 653–659

    Google Scholar 

  • Harenberg J (1987) Modified anti-factor Xa chromogenic substrate assay for heparin and low molecular weight heparin. Ärztl Lab 33: 39–41

    CAS  Google Scholar 

  • Harenberg J, Augustin J (1986, a) Lipolytic activities of low molecular weight heparins. Thromb Res 42:865–866

    Article  CAS  Google Scholar 

  • Harenberg J, Augustin J (1987, b) Antithrombotic action of hepatic triglyceride lipase - fact or fiction. Thrombos Haemostas 57:241

    CAS  Google Scholar 

  • Harenberg J, de Vries JX (1983) Characterization of heparins by high performance size exclusion liquid chromatography. J Chromatogr 261: 287

    Article  CAS  Google Scholar 

  • Harenberg J, Giese Ch, Dempfle CE, Stehle G, Heene DL (1988a) Monitoring of heparin and low molecular weight heparin with capillary and venous whole blood. Thrombos Haemostas 60: 377–381

    CAS  Google Scholar 

  • Harenberg J, Giese Ch, Dempfle CE, Stehle G, Heene DL (1989, c) Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteers. Thrombos Haemostas 61:357–362

    CAS  Google Scholar 

  • Harenberg J, Giese Ch, Knödler A, Zimmermann R (1986, b) Anti-factor Xa clotting method for heparin and low molecular weight heparins. Ärztl Lab 32:181–184

    CAS  Google Scholar 

  • Harenberg J, Giese Ch, Knödler A, Zimmermann R (1989, a) Comparative study on a new one-stage clotting assay for heparin and its low molecular weight derivatives. Haemostasis 19:13–20

    CAS  Google Scholar 

  • Harenberg J, Gnasso A, de Vries JX, Zimmermann R, Augustin J (1985) Anticoagulant and lipolytic effects of a low molecular weight heparin fraction. Thromb Res 39: 683–692

    Article  PubMed  CAS  Google Scholar 

  • Harenberg J, Heene DL (1988, b) Pharmacology and special clinical applications of lowmolecular-weight heparins. Am J Hematol 29:233–240

    Article  CAS  Google Scholar 

  • Harenberg J, Kallenbach B, Martin U, Dempfle CE, Zimmermann R, Kübler W, Heene DL (1990) Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients. Thromb Res (in press)

    Google Scholar 

  • Harenberg J, Leber G, Augustin J, Raedsch R, Schwarz F, Stiehl A, Zimmermann R (1987, a) Long term prophylaxis of thromboembolism with low molecular weight heparin. K1in Wschr 65:331–337

    Article  CAS  Google Scholar 

  • Harenberg J, Leber G, Dempfle CE, Heene DL, Zimmermann R, Kübler W (1989, b) Long term anticoagulation with low molecular weight heparin in outpatients with side effects on oral anticoagulants. Nouv Rev Fr Hematol 31:363–369

    CAS  Google Scholar 

  • Harenberg J, Stehle G, Dempfle CE, von Hodenberg E, Heene DL (1989, d) Influence of the low molecular weight Heparin CY 216. on lipases and blood coagulation. Ärzt Lab 35:73–79

    Google Scholar 

  • Holm HA, Abildgaard U (1982) Heparin treatment of deep venous thrombosis: correlation between clinical effects and heparin assays. In: Witt J (ed), Heparin–New Biochemical and Medical Aspects. Walter de Gruyter & Co., Berlin, New York, pp 289–300

    Google Scholar 

  • Holm HA, Ly B, Handeland GF, Abildgaard U, Arnesen KE, Gottschalk P, Hoeg V, Aandahl M, Haugen K, Laerum F, Scheel B, Sortland O, Vinje B (1986) Subcutaneous heparin treatment of deep venous thrombosis: A comparison of unfractionated and low molecular weight heparin. Haemostasis 16: 30–37

    PubMed  Google Scholar 

  • Janvier G, Winnock S, Dugrais G, Vallet A, Dardel E, Serise JM, Calen S, Vergnes C, Toulemonde F (1987) Treatment of deep venous thrombosis with a very low molecular weight heparin fragment (CY 222). Haemostasis 7: 49–58

    Google Scholar 

  • Kakkar VV, Djazaeri B, Fok J, Fletcher M, Scully MF, Westwick J (1982) Low-molecular weight heparin and prevention of postoperative deep vein thrombosis. Brit Med J 284: 375–379

    Article  CAS  Google Scholar 

  • Owren PA (1959) Thrombotest — a new method for controlling anticoagulant therapy. Lancet II:754–756

    Article  Google Scholar 

  • Teien AN, Abildgaard U, Höök M, Lindahl U (1977) Anticoagulation activity of heparin: assay of bovine, human and porcine preparations by amidolytic and clotting methods. Thromb Res 11: 107–117

    Article  PubMed  CAS  Google Scholar 

  • Teien AN, Lie M (1975) Heparin assay in plasma: A comparison of five clotting methods. Thromb Res 7: 777–788

    Article  PubMed  CAS  Google Scholar 

  • Turpie AGG, Levine MN, Hirsh J, Carter CJ, Jay RM, Powers PJ, Andrew M Hull, RD, Gent M (1986) A randomized controlled trial of a low-molecular weight heparin ( Enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. New Engl J Med 315: 925–929

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 1. Medical Clinic, Klinikum Mannheim, Faculty of Clinical Medicine of the University of Heidelberg, Theodor Kutzer Ufer, 6800, Mannheim, Germany

    Job Harenberg

Authors
  1. Job Harenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. I. Medizinische Klinik, Fakultät Klinische Medizin Mannheim, Ruprecht-Karls-Universität Heidelberg, Theodor-Kutzer-Ufer, 6800, Mannheim, Germany

    Job Harenberg , Dieter L. Heene  & Gerd Stehle ,  & 

  2. Karlstraße 4, 6900, Heidelberg, Germany

    Gotthard Schettler (Leiter, Präsident der Heidelberger Akademie der Wissenschaften (bis 30.9 1990) (Leiter, Präsident der Heidelberger Akademie der Wissenschaften (bis 30.9 1990)

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Harenberg, J. (1990). Clinical Pharmacologal Profile of Low Molecular Weight Heparins. In: Harenberg, J., Heene, D.L., Stehle, G., Schettler, G. (eds) New Trends in Haemostasis. Veröffentlichungen aus der Geomedizinischen Forschungsstelle der Heidelberger Akademie der Wissenschaften, vol 1990 / 1990/3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84318-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-84318-1_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-53275-0

  • Online ISBN: 978-3-642-84318-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation